What is the official website of Sandoz Österreich ?

The official website of Sandoz Österreich is https://www.sandoz.at/.

What is Sandoz Österreich's cybersecurity risk score?

Sandoz Österreich has an AI-generated cybersecurity risk score of 753 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Sandoz Österreich experienced?

According to Rankiteo, Sandoz Österreich currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Sandoz Österreich been affected by any supply chain cyber incidents ?

According to Rankiteo, Sandoz Österreich has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Sandoz Österreich have SOC 2 Type 1 certification ?

According to Rankiteo, Sandoz Österreich is not certified under SOC 2 Type 1.

Does Sandoz Österreich have SOC 2 Type 2 certification ?

According to Rankiteo, Sandoz Österreich does not hold a SOC 2 Type 2 certification.

Does Sandoz Österreich comply with GDPR ?

According to Rankiteo, Sandoz Österreich is not listed as GDPR compliant.

Does Sandoz Österreich have PCI DSS certification ?

According to Rankiteo, Sandoz Österreich does not currently maintain PCI DSS compliance.

Does Sandoz Österreich comply with HIPAA ?

According to Rankiteo, Sandoz Österreich is not compliant with HIPAA regulations.

Does Sandoz Österreich have ISO 27001 certification ?

According to Rankiteo,Sandoz Österreich is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Sandoz Österreich operate in ?

Sandoz Österreich operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does Sandoz Österreich have ?

Sandoz Österreich employs approximately 189 people worldwide.

Does Sandoz Österreich own any subsidiaries ?

Sandoz Österreich presently has no subsidiaries across any sectors.

How many LinkedIn followers does Sandoz Österreich have ?

Sandoz Österreich's official LinkedIn profile has approximately 8,025 followers.

What is the NAICS classification code for Sandoz Österreich ?

Sandoz Österreich is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does Sandoz Österreich have a Crunchbase profile ?

No, Sandoz Österreich does not have a profile on Crunchbase.

Does Sandoz Österreich have a LinkedIn profile ?

Yes, Sandoz Österreich maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/sandoz-austria.

How many cybersecurity incidents has Sandoz Österreich experienced ?

As of September 14, 2026, Rankiteo reports that Sandoz Österreich has not experienced any cybersecurity incidents.

How many peer or competitor companies does Sandoz Österreich have ?

Sandoz Österreich has an estimated 5,760 peer or competitor companies worldwide.

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

Sandoz Österreich

Boost Score +25 with badge (5 left)

753

/1000

Fair

778

/1000

Fair

Sandoz Österreich Vendor Cyber Rating & Cyber Score

sandoz.at

Add Your Compliance Badge

💙Bei Sandoz haben wir ein klares Ziel: der Welt Zugang zu lebensrettenden Medikamenten zu geben - und das seit über 77 Jahren in Österreich. 💊Die Entdeckung von Penicillin hat die Medizin revolutioniert. Unser österreichisches Werk, im Herzen Tirols, hat schon in der Nachkriegszeit mit der Penicillin-Produktion begonnen. Hier gelang es auch erstmals, Penicillin in Tablettenform herzustellen. Eine medizinische Sensation. 🏭Damals wurde eine stillgelegte Brauerei in eine biochemische Fabrik umgewidmet. Heute produziert das Werk über 4000 Tonnen an Wirkstoffen im Jahr. 🏰Voller Pioniergeist stellen wir die letzte große Penicillin-Hochburg der westlichen Welt – vom Wirkstoff bis zur Tablette wird in Kundl Antibiotika für den ganzen

Sandoz Österreich

Sandoz Österreich CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

Sandoz Österreich Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for Sandoz Österreich

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Sandoz Österreich in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Sandoz Österreich in 2026.

Incident Types Sandoz Österreich vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Sandoz Österreich in 2026.

Incident History - Sandoz Österreich (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Sandoz Österreich Subsidiaries

Sandoz Österreich

Pharmaceutical Manufacturing

Website: https://www.sandoz.at/

Company Size: 1,001-5,000 employees

SandozPharmaceutical Manufacturing

Sandoz do BrasilFabricação de produtos farmoquímicos e farmacêuticos

Sandoz EgyptPharmaceutical Manufacturing

Sandoz ItaliaPharmaceutical Manufacturing

Sandoz MéxicoPharmaceutical Manufacturing

Sandoz CanadaPharmaceutical Manufacturing

Sandoz IberiaPharmaceutical Manufacturing

Sandoz FrancePharmaceutical Manufacturing

Sandoz PolskaPharmaceutical Manufacturing

Sandoz Czech RepublicPharmaceutical Manufacturing

Sandoz India Pvt LtdPharmaceutical Manufacturing

Sandoz HrvatskaPharmaceutical Manufacturing

Sandoz SrbijaPharmaceutical Manufacturing

Sandoz UK & IrelandPharmaceutical Manufacturing

Sandoz Australia & New ZealandPharmaceutical Manufacturing

Sandoz NederlandPharmaceutical Manufacturing

Sandoz HungáriaPharmaceutical Manufacturing

Lek PharmaceuticalsPharmaceutical Manufacturing

Sandoz SverigePharmaceutical Manufacturing

Sandoz DanmarkPharmaceutical Manufacturing

Sandoz RomaniaPharmaceutical Manufacturing

Loading…

Sandoz Österreich Similar Companies

Takeda

cb takeda.com

We strive to transform lives. While the science we advance is constantly evolving, our core purpose is enduring. For more than two centuries, our values have guided us to do what’s right for patients and for society. We know that changing lives requires us to do things differently. We start by listening to and addressing what really matters to patients, the people who love them, and those in the healthcare system who provide care. And that’s what inspires us all to be bold, push boundaries and set new standards that open up greater opportunities. Read our community guidelines: https://takeda.info/communityguidelines

Servier

servier.com

Founded to serve health 70 years ago, Servier is a global pharmaceutical group governed by a non-profit Foundation that aspires to make a meaningful social impact for patients and for a sustainable world. The Group’s unique governance model preserves its independence and means it can fully serve its vocation of being committed to therapeutic progress to serve patient needs while adopting a long-term vision. Its employees are fully committed to this shared vocation, which serves as a source of inspiration every day. A world leader in cardiometabolism and venous diseases, Servier has made a major shift into oncology, which represents a new pillar of strategic growth. The Group devotes close to 70% of its R&D budget to this field, with the ambition of becoming a focused and innovative player in the development of treatments targeting rare cancers. Neurology will constitute a future growth driver. Servier is focusing on a limited number of diseases in this area where accurate patient profiling makes it possible to offer a targeted therapeutic response through precision medicine. To promote widespread access to quality care at a lower cost, the Group also offers a range of quality generic drugs covering most pathologies, leveraging well-known brands in France, and Eastern Europe. In all these areas, the Group takes patient considerations into account at every stage of the medicine life cycle. Headquartered in France, Servier relies on committed teams and strong geographical footprint; its medicines are available in close to 140 countries. In 2023/2024, the Group achieved sales revenue of €5.9 billion and EBITDA of €1.3 billion in 2024 (22.2%). Today, the Group employs over 22,000 people worldwide. -- To report a suspected adverse event with a Servier drug, please visit servier.com

AbbVie

cb abbvie.com

AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, aesthetics and other areas of unmet need. Learn more about us at www.abbvie.com and review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html.

MACLEODS PHARMACEUTICALS LTD.

macleodspharma.com

A vertically integrated, Global Pharmaceutical Company. Established in 1989, we are engaged in developing, manufacturing, and marketing a wide range of formulations across several major therapeutic areas including anti-infectives, cardiovascular, anti-diabetic, dermatology, and hormone treatment. We develop, manufacture, and globally distribute a broad range of pharmaceutical products across therapies in multiple dosage forms such as solid orals, liquid orals, topical formulations, injectables (Dry Powder) metered dose inhalers and dry powder inhalers. Our Vision To be a leading global pharmaceutical company by providing high quality, affordable and innovative therapeutic solutions for patients with diverse medical needs. Our Mission To contribute towards improving patients’ quality of life across the globe, by providing effective and accessible medicines.

Dr. Reddy's Laboratories

drreddys.com

Established in 1984, we are a global pharmaceutical company headquartered in Hyderabad, India. Driven by our purpose of ‘Good Health Can’t Wait’, we work to provide access to affordable and innovative medicines. We offer a portfolio of products and services including APIs, generics, branded generics, biosimilars and OTC. Our major markets include USA, India, Russia & CIS countries, China, Brazil and Europe. As a company with a history of deep science that has led to several industry firsts, we continue to plan ahead and invest in future growth drivers such as access to novel molecules, digital therapeutics and consumer healthcare. As an early adopter of sustainability and ESG actions, we released our first Sustainability Report in 2004. Our current ESG goals aim to set the bar high in environmental stewardship; access and affordability for patients; diversity; and governance. For more information, log on to: www.drreddys.com. Caution Notice: Dr. Reddy's has been made aware of candidates receiving fraudulent job opportunities from unauthorised recruiting agencies or people impersonating Dr. Reddy's leaders. These fraudulent jobs may be advertised on employment sites or mimic our careers site and company email addresses. Please know that Dr. Reddy's Laboratories has no affiliation or connection to these situations. Dr. Reddy's (and its associated/group companies) follows a formal recruitment process through its own HR department. Please report immediately in case you suspect a fraudulent job. You may raise your concern by: Accessing https://drreddys.ethicspoint.com. Calling on the hotline number. List of hotline numbers are available in https://drreddys.ethicspoint.com. The hotline is available 24x7 in multiple languages. Writing to [email protected] or [email protected]. For our community guidelines on LinkedIn, please visit: https://shorturl.at/LTvNZ

Viatris

viatris.com

Viatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale. In 2022 alone, we supplied high-quality medicines to approximately 1 billion patients around the world. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world’s most enduring health challenges, access takes on deep meaning at Viatris. We have the ability to touch all of life’s moments, from birth to end of life, acute conditions to chronic diseases. We are headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India Social Media Guidelines: https://newsroom.viatris.com/social-media-community-guidelines Investors: https://investor.viatris.com Corporate Social Responsibility: https://www.viatris.com/sustainability Connect with Viatris Instagram: https://www.instagram.com/viatrisinc X: https://www.x.com/viatrisinc Viatris and our recruiting firms will not ask for sensitive personal information, such as your social security number, date of birth or bank account details via text, email or social media. Additionally, Viatris representatives do not request payment or personal bank information nor send payment to purchase hardware on your own. Viatris.com is the primary source of all company job postings and authorized third-party career websites.

Intas Pharmaceuticals

intaspharma.com

Intas is one of the leading multinational pharmaceutical formulation development, manufacturing, and marketing organization in the world. It has been growing at 19% CAGR and crossed the $2.5 billion mark in the past financial year. The company has set up a network of subsidiaries, under the name Accord Healthcare in the EU, US, Canada, SA, Australia, APAC as well as CIS & MENA regions. Intas is present in 85+ countries, with more than 70% of its revenue coming from global business. Currently ranked 6th in the Indian pharmaceutical market, it’s the largest privately owned Indian generic pharma company. Intas has established leadership in key therapeutic segments like CNS, Cardio, Diabeto, Gastro, Urology, Oncology & Animal Health in India. We are among the top 10 generic players in the highly regulated markets of EU, US & UK. Intas operates 17 advanced formulations, R&D, and distribution facilities, of which 10 are in India and the rest in the UK, Mexico & Greece with the help of our 23,000+ Human Capital. Between them, the facilities are accredited by global regulators such as USFDA, EMA, MHRA, TGA, and others. The company invests ~6-7% of its revenues in R&D and has over 10,000 product registrations worldwide with a strategic pipeline of 300+ high-value FTF/FTM, Biosimilars, and NDDS products. Intas' highly advanced EU-GMP Certified Biopharma division is fueled by a mission to provide affordable “Biosimilars for Billions” across niche segments such as oncology, auto-immune, ophthalmology, nephrology, rheumatology, and hormone-based therapies. The Plasma Fractionation Unit of Intas Pharmaceuticals is a pioneer in manufacturing plasma-derived therapeutics. It houses a full-fledged R&D lab and a state-of-the-art WHO-GMP-certified manufacturing facility complemented with a GLP-compliant QC lab. Our values of Innovation, Customer Delight, Ownership & Collaboration, Performance Focus & Care for Society are the driving forces toward excellence.

Zoetis

zoetis.com

The world’s leading animal health company. We’ve been innovating ways to predict, prevent, detect, and treat animal illness for over 70 years, and we continue to stand by those raising and caring for animals worldwide – from veterinarians and pet owners to livestock farmers. Our leading portfolio and pipeline makes a difference in over 100 countries. Community Guidelines: This page is intended to share how Zoetis is advancing care for animals. We aspire to create a supportive community, but there are guidelines to which posts and comments on this page must adhere. If your post references a side effect related to any Zoetis product, we may contact you for more information. To monitor the safety of Zoetis products, we advise you to call our Veterinary Medical Information and Product Support Team at 1-888-963-8471; Support Team is available Mon-Fri 9am to 6:30pm ET. We reserve the right to remove any post/comment that violates LinkedIn Guidelines. As a last resort, we reserve the right to block users that demonstrate a repeated pattern of violating LinkedIn’s spirit of constructive, professional discourse. We respectfully request that you refrain from posting comments including: Unsolicited and/or unverified medical advice Vulgarity and/or profanity Discriminatory and/or derogatory comments, hate speech Politics and religion Personal attacks and/or threats Promotion of illegal activity Copyright/trademark infringements Topics that may be considered spam/advertising Our regular business hours are Mon-Fri 9am to 5pm ET. Zoetis does not endorse and is not responsible for information and opinions shared by community members. The information shared is provided for educational purposes only and is not intended to replace discussions with an animal healthcare professional. Testimonials represent individual experience only and the experiences and opinions of community members may be unique to the speaker. Terms of Use: https://www.zoetis.com/terms-of-use

Ipca Laboratories Limited

ipca.com

A consumer-led global pharmaceutical company, creating healthy doses of life since 1949. When you operate in an industry like pharmaceuticals, your work goes way beyond creating ‘products for customers’. It is different from any other domain – there lies a higher sense of responsibiliti and a need for utmost integriti in everything you do. As you serve millions of lives, high qualiti standards become a pre-requisite, and safeti of your people and consumers always comes first. All this, while ensuring that each life you touch is treated with respect and digniti. For more than 60 years, Ipca has been a crucial healthcare partner in over 120 countries across the 6 continents. We are a fully-integrated pharmaceutical company that manufactures over 350 formulations and 80 APIs for various therapeutic segments. Today, we are one of the world’s largest manufacturers and suppliers of over a dozen APIs. These are produced from scratch at fully-automated manufacturing facilities, approved by the world’s most discerning drug regulatory authorities like UK-MHRA, EDQM-Europe, and WHO-Geneva, among others. - One of the largest suppliers of these APIs worldwide with manufacturing leadership in over 12 APIs globally - 15 APIs & 11 Formulations manufacturing facility across the globe Leader in DMARDs (Disease Modifying Anti-Rheumatic Drugs) treatment for Rheumatoid Arthritis - Leading brands in Pain, Rheumatology, Antimalarials and Hair care therapy - 4 formulations rank amongst the top 300 brands of IPM as per IQVIA

Loading…

NEWS

Sandoz Österreich CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

April 02, 2024 07:00 AM

Sandoz Antibiotic Manufacturing Facility, Kundl, Austria

Sandoz, a generic pharmaceuticals company based in Switzerland, opened an antibiotic manufacturing facility in Kundl, Austria, in November 2023.

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-90603

SUMMARY

A vulnerability was identified in Anil-matcha Open-Generative-AI up to 1.0.11/2.0.0. Affected by this issue is some unknown functionality of the file /api/upload-binary of the component S3 Upload. Such manipulation of the argument x-proxy-target-url leads to unrestricted upload. The attack may be launched remotely. The name of the patch is f013270957f75e439eaf97eb2a93decb32a4543e. Applying a patch is advised to resolve this issue.

Published

Date2026-09-13

Updated

Date2026-09-13

RISK INFORMATION (Score: 7.3)

cvss2

Base Score: 7.5

Complexity: LOW

AV:N/AC:L/Au:N/C:P/I:P/A:P

cvss3

Base Score: 7.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 6.9

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

3.9

REFERENCES

CVE-2026-90602

SUMMARY

A vulnerability was determined in Anil-matcha Open-Generative-AI up to 1.0.11/2.0.0. Affected by this vulnerability is the function renderHistory of the file ImageStudio.js of the component Studio Components. This manipulation causes cross site scripting. The attack may be initiated remotely. The pull request to fix this issue awaits acceptance.

Published

Date2026-09-13

Updated

Date2026-09-13

RISK INFORMATION (Score: 3.5)

cvss2

Base Score: 4.0

Complexity: LOW

AV:N/AC:L/Au:S/C:N/I:P/A:N

cvss3

Base Score: 3.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:U/C:N/I:L/A:N

cvss4

Base Score: 5.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:P/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

1.4

Exploitability

2.1

REFERENCES

CVE-2026-90601

SUMMARY

A vulnerability was found in getzep graphiti up to 0.30.2. Affected is an unknown function of the file server/graph_service/main.py of the component REST API. The manipulation results in improper authentication. The attack can be launched remotely. The pull request to fix this issue awaits acceptance.

Published

Date2026-09-13

Updated

Date2026-09-13

RISK INFORMATION (Score: 7.3)

cvss2

Base Score: 7.5

Complexity: LOW

AV:N/AC:L/Au:N/C:P/I:P/A:P

cvss3

Base Score: 7.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 6.9

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

3.9

REFERENCES

CVE-2026-90600

SUMMARY

A vulnerability has been found in itsourcecode Sales and Inventory System 1.0. This impacts an unknown function of the file /pages/inv_edit1.php. The manipulation of the argument ID leads to sql injection. The attack can be initiated remotely. The exploit has been disclosed to the public and may be used.

Published

Date2026-09-13

Updated

Date2026-09-13

RISK INFORMATION (Score: 6.3)

cvss2

Base Score: 6.5

Complexity: LOW

AV:N/AC:L/Au:S/C:P/I:P/A:P

cvss3

Base Score: 6.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

2.8

REFERENCES

CVE-2026-15892

SUMMARY

The mcumgr SMP settings-management group handlers settings_mgmt_read(), settings_mgmt_write(), and settings_mgmt_delete() in subsys/mgmt/mcumgr/grp/settings_mgmt/src/settings_mgmt.c allocate a key_name buffer (and, for read, a data buffer) via k_malloc() when CONFIG_MCUMGR_GRP_SETTINGS_BUFFER_TYPE_HEAP is enabled, relying on the end: label to k_free() them. When CONFIG_MCUMGR_GRP_SETTINGS_ACCESS_HOOK is also enabled and the application access hook rejects a request by returning status MGMT_CB_ERROR_RC, the handler executed return ret_rc; directly, bypassing end: and leaking the heap allocation on every rejected request. The settings handlers are reachable over the unauthenticated SMP transport (Bluetooth LE, UART, or UDP, depending on product configuration). The access hook is the mechanism applications use to deny unauthorized settings access, and MGMT_CB_ERROR_RC is a common rejection style, so an attacker who can send settings read/write/delete commands that the hook rejects triggers a heap leak on each attempt. Because the leaked memory is never reclaimed until reboot, a sustained stream of rejected requests monotonically exhausts the kernel heap until k_malloc() fails, denying mcumgr service and impacting any other heap consumer on the device — a denial of service. The impact is availability-only; there is no memory corruption or information disclosure. Only configurations that select the heap buffer type, enable the access hook, and register a hook that returns MGMT_CB_ERROR_RC are affected (the default stack buffer type cannot leak).

Published

Date2026-09-13

Updated

Date2026-09-13

RISK INFORMATION (Score: 5.3)

cvss3

Base Score: 5.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:L

Impact Score

1.4

Exploitability

3.9

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…

Badge your company to reduce your risk score and your cyber insurance costs!

Trusted by insurers. Chosen by leaders.

Sandoz Österreich Vendor Cyber Rating & Cyber Score

Sandoz Österreich A.I CyberSecurity Scoring

Sandoz Österreich CyberSecurity News & History

Sandoz Österreich Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for Sandoz Österreich

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types Sandoz Österreich vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - Sandoz Österreich (X = Date, Y = Severity)

Sandoz Österreich Subsidiaries

Sandoz Österreich

Sandoz Österreich Similar Companies

Takeda

Servier

AbbVie

MACLEODS PHARMACEUTICALS LTD.

Dr. Reddy's Laboratories

Viatris

Intas Pharmaceuticals

Zoetis

Ipca Laboratories Limited

Sandoz Österreich CyberSecurity News

Sandoz Antibiotic Manufacturing Facility, Kundl, Austria

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo

Sandoz Österreich CyberSecurity News & History

Sandoz Österreich Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for Sandoz Österreich

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types Sandoz Österreich vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - Sandoz Österreich (X = Date, Y = Severity)

Sandoz Österreich Subsidiaries

Sandoz Österreich

Sandoz Österreich Similar Companies

Takeda

Servier

AbbVie

MACLEODS PHARMACEUTICALS LTD.

Dr. Reddy's Laboratories

Viatris

Intas Pharmaceuticals

Zoetis

Ipca Laboratories Limited

Sandoz Österreich CyberSecurity News

Sandoz Antibiotic Manufacturing Facility, Kundl, Austria

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo